Related references
Note: Only part of the references are listed.Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis
Mariaelena Pierobon et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Phenotypic impact of genomic structural variation: insights from and for human disease
Joachim Weischenfeldt et al.
NATURE REVIEWS GENETICS (2013)
Aromatase, breast cancer and obesity: a complex interaction
Serdar E. Bulun et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
Rare Copy Number Variants Observed in Hereditary Breast Cancer Cases Disrupt Genes in Estrogen Signaling and TP53 Tumor Suppression Network
Katri Pylkas et al.
PLOS GENETICS (2012)
Germline DNA copy number variation in familial and early-onset breast cancer
Ana C. V. Krepischi et al.
BREAST CANCER RESEARCH (2012)
Thrombin-cleaved osteopontin regulates hemopoietic stem and progenitor cell functions through interactions with α9β1 and α4β1 integrins
Jochen Grassinger et al.
BLOOD (2009)
CYP2C19*17 is associated with decreased breast cancer risk
Christina Justenhoven et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Loss of Integrin alpha 9 beta 1 Results in Defects in Proliferation, Causing Poor Re-Epithelialization during Cutaneous Wound Healing
Purva Singh et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Increased omeprazole metabolism in carriers of the CYP2C19*17 allele;: a pharmacokinetic study in healthy volunteers
R. Michael Baldwin et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Triple-Negative Breast Cancer: Risk Factors to Potential Targets
Bryan P. Schneider et al.
CLINICAL CANCER RESEARCH (2008)
The emerging landscape of breast cancer susceptibility
Michael R. Stratton et al.
NATURE GENETICS (2008)
Chronic inflammation and oxidative stress in human carcinogenesis
Alessandro Federico et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
Paul R. Burton et al.
NATURE (2007)
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
Lisa A. Carey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Role of polymorphic human cytochrome P450 enzymes in estrone oxidation
AE Cribb et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
A common novel CTP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants
SC Sim et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Genomic disorders: Molecular mechanisms for rearrangements and conveyed phenotypes
JR Lupski et al.
PLOS GENETICS (2005)
Serum sex steroids in premenopausal women and breast cancer risk within the European prospective investigation into cancer and nutrition (EPIC)
R Kaaks et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in breast cancer
H Dote et al.
CLINICAL CANCER RESEARCH (2004)
Metabolism of tamoxifen by recombinant human cytochrome P450 enzymes:: Formation of the 4-hydroxy, 4′-hydroxy and N-desmethyl metabolites and isomerization of trans-4-hydroxytamoxifen
HK Crewe et al.
DRUG METABOLISM AND DISPOSITION (2002)
The cytoplasmic domain of the integrin α9 subunit requires the adaptor protein paxillin to inhibit cell spreading but promotes cell migration in a paxillin-independent manner
BA Young et al.
MOLECULAR BIOLOGY OF THE CELL (2001)
Poor metabolizers at the cytochrome P450 2D6 and 2C19 loci are at increased risk of developing adult acute leukaemia
PL Roddam et al.
PHARMACOGENETICS (2000)
Share Paper
